Robots like Digit are purpose-built to do tasks in environments made for humans. We aren’t trying to just mimic the look of people or make a humanoid robot.
Every design and engineering decision is looked at through a function-first lens. To easily walk into warehouses and work alongside people, to do the kinds of dynamic reaching, carrying, and walking that we do, Digit has some similar characteristics.
Trey Parker and Matt Stone’s AI studio Deep Voodoo said Wednesday that it has secured a $20 million in an investment round led by Connect Ventures. The South Park creators’ startup said it will use the capital to accelerate its development of deep-fake technology, VFX services and original synthetic media projects.
Connect Ventures is an investment partnership between CAA and venture capital firm New Enterprise Associates and represents the first outside capital raise for Deep Voodoo, which was previously funded by Parker and Stone’s entertainment company Park County.
Parker and Stone originally began building out their deep fake technology in early 2020, assembling a team of artists for a feature film they had developed. When the film was suspended amid the Covid shutdown, they pivoted to building out those deep-fake tools.
For some, automation will usher in a labor-free utopia; for others, it signals a disastrous age-to-come. Yet whether seen as dream or nightmare, automation, argues Munn, is ultimately a fable that rests on a set of triple fictions. There is the myth of full autonomy, claiming that machines will take over production and supplant humans. But far from being self-acting, technical solutions are piecemeal; their support and maintenance reveals the immense human labor behind autonomous processes. There is the myth of universal automation, with technologies framed as a desituated force sweeping the globe. But this fiction ignores the social, cultural, and geographical forces that shape technologies at a local level. And, there is the myth of automating everyone, the generic figure of the human at the heart of automation claims. But labor is socially stratified and so automation’s fallout will be highly uneven, falling heavier on some (immigrants, people of color, women) than others. Munn moves from machine minders in China to warehouse pickers in the United States to explore the ways that new technologies do (and don’t) reconfigure labor. Combining this rich array of human stories with insights from media and cultural studies, Munn points to a more nuanced, localized, and racialized understanding of the future of work.
From a vaccine for respiratory syncytial virus (RSV) to an infusion that slowed down Alzheimer’s for some people with the disease, here are three momentous advances from 2022.
An RSV vaccine showed promise for the first time in 50-years
Two vaccines are poised to be approved for RSV by the end of 2023, according to their makers, after almost 50-years without any meaningful progress.
In a recent study published in Cell Reports, researchers performed a genomic analysis to investigate the origination of human microproteins of biological importance.
Studies have reported that sORFs (small open reading frames) encode functional microproteins essential for several biological processes. However, the origination and conservation of such microproteins have not been well-characterized. Genomic analysis of microproteins could deepen understanding of human genomic characteristics critical for functionality.
Sarojini Mohanta from Odisha nurtured each of the saplings in a patch of the Bonai Forest Division as her own. Today, this forestland is named ‘Sarojini Vana’ in her honour.
In a study examining the link between non-alcoholic fatty liver disease (NAFLD) and brain dysfunction, scientists at the Roger Williams Institute of Hepatology, affiliated to King’s College London and the University of Lausanne, found an accumulation of fat in the liver causes a decrease in oxygen to the brain and inflammation to brain tissue—both of which have been proven to lead to the onset of severe brain diseases.
The paper appears in the Journal of Hepatology.
NAFLD affects approximately 25% of the population and more than 80% of morbidly obese people. Several studies have reported the negative effects of an unhealthy diet and obesity can have on brain function however this is believed to be the first study that clearly links NAFLD with brain deterioration and identifies a potential therapeutic target.